Long-acting insulin analogue
Insulin Glargine in Switzerland: prescription, brands, pricing
This page summarises the situation of Insulin Glargine in Switzerland under Swissmedic (Swiss Agency for Therapeutic Products): prescription status, available brands and generics, pharmacy dispensing, and online options in CHF. Insulin Glargine belongs to the Long-acting insulin analogue class.
- Regulator
- Swissmedic (Swiss Agency for Therapeutic Products)
- Currency
- CHF
About Insulin Glargine
Insulin glargine is approved as basal insulin therapy in adults and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus when oral or non-insulin injectable therapy is insufficient or contraindicated… Switzerland classifies medicines into categories A and B (prescription-only), C (sold under pharmacist supervision), D (over-the-counter at pharmacies and Drogerien) and E (general retail). Health insurance (Krankenversicherung) covers most prescription costs subject to a deductible (Franchise) and co-payment.
Mechanism and action
Insulin glargine binds the insulin receptor with similar affinity to human insulin, activating intracellular signalling that increases glucose uptake in muscle and adipose tissue, suppresses hepatic glucose production and promotes lipogenes…
Brands and generics in Switzerland
In Switzerland, Insulin Glargine is typically dispensed as one internationally recognised brand along with their corresponding authorised generics. Swiss Apotheken/pharmacies are densely distributed with strict licensing; pharmacist counselling is integral to dispensing. Drogerien (drugstores) are unique to the Swiss system and sell category D and E medications without a pharmacist on staff. Brand-to-generic substitution is decided by the pharmacist under local Swissmedic (Swiss Agency for Therapeutic Products) equivalence rules, and the price difference in CHF is usually substantial.
Online and tele-prescribing access
Swiss online prescription dispensing is regulated by cantonal law, with Swissmedic-licensed services offering tele-prescribing. Cross-border importation for personal use is restricted to small quantities and excludes some controlled substances. For Insulin Glargine specifically, the legal online options in Switzerland depend on its Rx-or-OTC classification under Swissmedic (Swiss Agency for Therapeutic Products).
Frequently asked questions
Is Insulin Glargine available in Switzerland? ▾
Yes — Insulin Glargine and its brands are available in Switzerland through pharmacies authorised by Swissmedic (Swiss Agency for Therapeutic Products), in various strengths depending on the commercial product. Authorised generics offer a lower-cost alternative with the same active substance.
Do I need a prescription for Insulin Glargine in Switzerland? ▾
Switzerland classifies medicines into categories A and B (prescription-only), C (sold under pharmacist supervision), D (over-the-counter at pharmacies and Drogerien) and E (general retail). Health insurance (Krankenversicherung) covers most prescription costs subject to a deductible (Franchise) and co-payment. The exact status of Insulin Glargine (Rx or OTC) is determined by Swissmedic (Swiss Agency for Therapeutic Products); most active ingredients in the Long-acting insulin analogue class require prescription, although there are exceptions by country and formulation.
How much does Insulin Glargine cost in Switzerland? ▾
The price in CHF depends on the manufacturer (brand vs authorised generic), the strength and the pack size. Generics are typically substantially cheaper than brands and serve as the economic reference for ongoing use.
Products with Insulin Glargine in Switzerland
Insulin Glargine in other countries
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.